Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,520,000 | 1,878,000 | 1,036,000 | 1,099,000 | 739,000 |
| Marketable Securities | 10,432,000 | 10,673,000 | 7,579,000 | 5,764,000 | 3,703,000 |
| Receivables | 8,636,000 | 5,785,000 | 4,798,000 | 5,489,000 | 3,864,000 |
| Inventories | 5,699,000 | 2,678,000 | 2,485,000 | 2,702,000 | 1,654,000 |
| Other current assets | 1,632,000 | 1,970,000 | 1,896,000 | 140,000 | 1,231,000 |
| TOTAL | $30,677,000 | $24,781,000 | $19,212,000 | $17,187,000 | $11,191,000 |
| Non-Current Assets | |||||
| PPE Net | 18,156,000 | 10,712,000 | 9,783,000 | 9,425,000 | 5,343,000 |
| Investments And Advances | 6,142,000 | 5,161,000 | 5,724,000 | 2,529,000 | 1,721,000 |
| Intangibles | 57,856,000 | 2,121,000 | 1,689,000 | 1,791,000 | 0 |
| Other Non-Current Assets | 3,944,000 | 3,581,000 | 2,745,000 | 2,578,000 | 2,319,000 |
| TOTAL | $86,098,000 | $21,575,000 | $19,941,000 | $16,323,000 | $9,383,000 |
| Total Assets | $116,775,000 | $46,356,000 | $39,153,000 | $33,510,000 | $20,574,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,818,000 | 8,669,000 | 6,263,000 | 4,289,000 | 0 |
| Accounts payable and accrued liabilities | 2,587,000 | 1,620,000 | 1,411,000 | 1,719,000 | 951,000 |
| Accrued Expenses | 1,740,000 | 1,084,000 | 1,026,000 | 982,000 | 669,000 |
| Other current liabilities | 5,850,000 | 3,448,000 | 2,866,000 | 3,445,000 | 1,695,000 |
| TOTAL | $23,909,000 | $18,555,000 | $13,729,000 | $11,981,000 | $9,185,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,755,000 | 3,140,000 | 2,609,000 | 1,123,000 | 525,000 |
| aiOther Non-Current Liabilities | 8,722,000 | 4,347,000 | 4,124,000 | 3,950,000 | 1,676,000 |
| TOTAL | $27,489,000 | $7,851,000 | $7,131,000 | $5,453,000 | $2,502,000 |
| Total Liabilities | $51,398,000 | $26,406,000 | $20,860,000 | $17,434,000 | $11,687,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,625,056 | 6,158,348 | 6,265,231 | N/A | N/A |
| Common Shares | 435,000 | 341,000 | 340,000 | 337,000 | 213,000 |
| Retained earnings | 29,382,000 | 30,243,000 | 24,430,000 | 19,599,000 | 13,396,000 |
| Other shareholders' equity | -1,484,000 | -3,661,000 | -4,399,000 | -4,897,000 | -3,287,000 |
| TOTAL | $65,377,000 | $19,950,000 | $18,293,000 | $16,076,000 | $8,887,000 |
| Total Liabilities And Equity | $116,775,000 | $46,356,000 | $39,153,000 | $33,510,000 | $20,574,000 |